Clinical Trials List
Protocol NumberPL3397-A-A103
Completed
2016-06-01 - 2017-12-31
Phase I
Terminated1
-
Trial Applicant
Daiichi Sankyo Taiwan Ltd.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chih-Hung Hsu Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
9-15 participants
-
Global
0 participants
